EBODAC – Vaccine Deployment, Acceptance and Compliance
The EBODAC project is developing strategies and tools to promote the acceptance and uptake of new Ebola vaccines, to help the right person receive the right vaccine at the right time.
EBODAC is important because the successful development and deployment of an Ebola vaccine is faced with many challenges, especially when working in resource limited settings. These include:
EBODAC is working to ensure the novel prime-boost vaccine regimen is well accepted and successfully used in the context of clinical trials; while also preparing to maximise the impact of the potential deployment of a future Ebola vaccination programme in West Africa.
EBODAC is currently supporting the EBOVAC-Salone clinical trial in Kambia District, Sierra Leone, and is using this opportunity to evaluate the three levers it has developed:
All components of the EBODAC platform are designed and developed to allow rapid scale-up should there be a need to eventually deploy a licensed vaccine.
EBOVAC-Salone participant receives mobile phone message supplied by the EBODAC project. (Credit: Anneleen Vuchelen)
The EBODAC consortium held a symposium on Communications, Community Engagement and Technologies in Ebola Clinical Trials on 20/21 February 2017. More information is available here.